Document is current
Any future updates will be listed below
-
Authors
Tinsley, Samantha L.
Chianis, Ella Rose D.
Shelley, Rebecca A. https://orcid.org/0000-0001-7162-6797
Mall, Gaganpreet K.
Dhiman, Alisha
Baral, Garima https://orcid.org/0000-0002-0074-921X
Kothandaraman, Harish https://orcid.org/0000-0002-0759-4601
Thoma, Mary C.
English, Isabel A.
Daniel, Colin J.
Acosta, Luis Carlos Sanjuan
Solorio, Luis
Atallah Lanman, Nadia https://orcid.org/0000-0002-1819-7070
Pasca di Magliano, Marina
Narla, Goutham https://orcid.org/0000-0003-4098-4203
Dykhuizen, Emily C. https://orcid.org/0000-0003-3072-1469
Sears, Rosalie C. https://orcid.org/0000-0003-1558-2413
Allen-Petersen, Brittany L. https://orcid.org/0000-0002-7436-9412
-
Funding
Funding for this research was provided by:
Concern Foundation
Pancreatic Cancer Action Network (22-20-ALLE)
Ross-Lynn Scholars Research Grant
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01 CA224012)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA186241)
- License Information
-
More Information
Article History
Received: 22 December 2023
Revised: 4 October 2024
Accepted: 11 October 2024
First Online: 23 October 2024
Competing interests
: G.N. receives research support from RAPPTA Therapeutics, and has an equity interest and receives consulting fees from RAPPTA Therapeutics. R.C.S serves on the scientific advisory board for RAPPTA and Larkspur, and receives sponsored research support from Cardiff Oncology and AstraZeneca. L.S. receives sponsored research support from Eli Lilly and Company. All other authors have no potential conflicts of interest.
: All methods were performed in accordance with relevant guidelines and regulations. All animal studies were performed in compliance with Purdue University (West Lafayette, IN) animal use guidelines after approval by the Purdue Institutional Animal Care and Use Committee (PACUC #1910001962).
